Observational Study of Meloxicam in Mexican Patients With Rheumatic Diseases

• Status: Completed
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: All

Summary

Observational study to evaluate the efficacy and safety of meloxicam (Mobicox®) in Mexican population with rheumatic diseases

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Boehringer Ingelheim
• Treatments: Meloxicam

Criteria

Inclusion Criteria:

• Age of 12 or older and rheumatologic disease

Exclusion Criteria:

• Hypersensitivity to meloxicam

• Hypersensitivity to other Non-steroidal anti-inflammatory drugs (NSAIDS)

• History of asthma, angioedema or urticaria secondary to NSAIDS

• Pregnancy or lactation

• Recent or current history of peptic ulcer disease, severe renal failure and severe hepatic failure